Author Correction: Downregulation of rhodopsin is an effective therapeutic strategy in ameliorating peripherin-2-associated inherited retinal disorders

MLA

Christian T. Rutan Woods, et al. “Author Correction: Downregulation of Rhodopsin Is an Effective Therapeutic Strategy in Ameliorating Peripherin-2-Associated Inherited Retinal Disorders.” Nature Communications, vol. 15, no. 1, July 2024, pp. 1–4. EBSCOhost, https://doi.org/10.1038/s41467-024-50140-3.

APA

Christian T. Rutan Woods, Mustafa S. Makia, Tylor R. Lewis, Ryan Crane, Stephanie Zeibak, Paul Yu, Mashal Kakakhel, Carson M. Castillo, Vadim Y. Arshavsky, Muna I. Naash, & Muayyad R. Al-Ubaidi. (2024). Author Correction: Downregulation of rhodopsin is an effective therapeutic strategy in ameliorating peripherin-2-associated inherited retinal disorders. Nature Communications, 15(1), 1–4. https://doi.org/10.1038/s41467-024-50140-3

Chicago

Christian T. Rutan Woods, Mustafa S. Makia, Tylor R. Lewis, Ryan Crane, Stephanie Zeibak, Paul Yu, Mashal Kakakhel, et al. 2024. “Author Correction: Downregulation of Rhodopsin Is an Effective Therapeutic Strategy in Ameliorating Peripherin-2-Associated Inherited Retinal Disorders.” Nature Communications 15 (1): 1–4. doi:10.1038/s41467-024-50140-3.